These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3749402)

  • 81. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
    Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Dexamethasone suppression testing in chronic renal failure: pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis.
    Workman RJ; Vaughn WK; Stone WJ
    J Clin Endocrinol Metab; 1986 Sep; 63(3):741-6. PubMed ID: 3734041
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Dexamethasone suppression test and plasma dexamethasone levels in bulimia.
    Walsh BT; Lo ES; Cooper T; Lindy DC; Roose SP; Gladis M; Glassman AH
    Arch Gen Psychiatry; 1987 Sep; 44(9):797-800. PubMed ID: 3632253
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Is conversion disorder biologically related with depression?: a DST study.
    Tunca Z; Fidaner H; Cimilli C; Kaya N; Biber B; Yeşil S; Ozerdem A
    Biol Psychiatry; 1996 Feb; 39(3):216-9. PubMed ID: 8837984
    [No Abstract]   [Full Text] [Related]  

  • 85. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns.
    Rubin RT; Poland RE; Lesser IM; Martin DJ; Blodgett AL; Winston RA
    Psychol Med; 1987 Aug; 17(3):609-19. PubMed ID: 3628622
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
    Kaneko M; Murata S; Hoshino Y; Takahagi K; Yokoyama F; Watanabe M; Kumashiro H
    Neuropsychobiology; 1990-1991; 24(1):12-6. PubMed ID: 2132636
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder.
    Casper RC; Swann AC; Stokes PE; Chang S; Katz MM; Garver D
    Acta Psychiatr Scand; 1987 Mar; 75(3):243-50. PubMed ID: 3473911
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    Vreeburg SA; Hoogendijk WJ; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Smit JH; Zitman FG; Penninx BW
    Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression.
    Roy A
    Biol Psychiatry; 1992 Nov; 32(9):812-6. PubMed ID: 1450295
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Neuroendocrine interrelationships in major depressive disorder.
    Targum SD; Sullivan AC; Byrnes SM
    Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
    Roy A; Jimerson DC; Pickar D
    Am J Psychiatry; 1986 Jul; 143(7):846-51. PubMed ID: 3717423
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania.
    Swann AC; Stokes PE; Casper R; Secunda SK; Bowden CL; Berman N; Katz MM; Robins E
    Acta Psychiatr Scand; 1992 Apr; 85(4):270-4. PubMed ID: 1595360
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG; Rifkin A; Reardon GT; Doddi SR; Foster P; Strahan A; Morgan V
    Biol Psychiatry; 1984 Sep; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract]   [Full Text] [Related]  

  • 97. Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.
    Maes M; Minner B; Suy E; Vandervorst C; Raus J
    J Neural Transm Gen Sect; 1991; 85(3):195-210. PubMed ID: 1930881
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Regression toward the mean: more on the price of beer and the salaries of priests.
    Gibbons RD; Hedeker D; Davis JM
    Psychoneuroendocrinology; 1987; 12(3):185-92. PubMed ID: 3615748
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium.
    Robertsson B; Blennow K; Bråne G; Edman A; Karlsson I; Wallin A; Gottfries CG
    Int Clin Psychopharmacol; 2001 Jan; 16(1):39-47. PubMed ID: 11195259
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Neuroendocrine aspects of primary endogenous depression. XIII. Influence of race on differences in hypothalamo-pituitary-adrenal and pituitary-thyroid function between patients and matched controls.
    Thompson LM; Rubin RT
    Biol Psychiatry; 1993 Dec; 34(12):893-5. PubMed ID: 8110917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.